Amgen (AMGN) Shares Outstanding (2009 - 2026)
Amgen (AMGN) posted quarterly Shares Outstanding (Entity) of $539.7 million for Q1 2026, little changed year-over-year from $537.7 million in Q1 2025, and little changed quarter-over-quarter from $538.8 million in Q4 2025.
Amgen (AMGN) Shares Outstanding (2009 - 2026) Analysis & Trends
Amgen's Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $539.7 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.37% year-over-year to $539.7 million; the TTM figure through Mar 2026 stood at $539.7 million (changed 0.37% YoY), while the FY2025 annual figure was $538.8 million, changed 0.35% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $539.7 million, roughly flat from $538.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $539.7 million in Q1 2026, with the low at $533.5 million in Q3 2022.
- The 5-year median for Shares Outstanding (Entity) is $536.4 million (2024), against an average of $536.3 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) retreated 7.14% in 2022, then rose 0.45% in 2024.
- Amgen's Shares Outstanding (Entity) stood at $534.0 million in 2022, then increased by 0.26% to $535.4 million in 2023, then increased by 0.28% to $536.9 million in 2024, then gained by 0.35% to $538.8 million in 2025, then grew by 0.17% to $539.7 million in 2026.
- Business Quant data shows AMGN's Shares Outstanding (Entity) at $539.7 million in Q1 2026, $538.8 million in Q4 2025, and $538.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.91 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 2.03 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 1.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 540.00 Mn |
| Mar 31, 2026 | 540.00 Mn |
| Dec 31, 2025 | 538.00 Mn |
| Sep 30, 2025 | 538.00 Mn |
| Jun 30, 2025 | 538.00 Mn |
| Mar 31, 2025 | 538.00 Mn |
| Dec 31, 2024 | 537.00 Mn |
| Sep 30, 2024 | 537.00 Mn |
| Jun 30, 2024 | 537.00 Mn |
| Mar 31, 2024 | 536.00 Mn |
| Dec 31, 2023 | 535.00 Mn |
| Sep 30, 2023 | 535.00 Mn |
| Jun 30, 2023 | 535.00 Mn |
| Mar 31, 2023 | 534.00 Mn |
| Dec 31, 2022 | 538.00 Mn |
| Sep 30, 2022 | 535.00 Mn |
| Jun 30, 2022 | 535.00 Mn |
| Mar 31, 2022 | 548.00 Mn |
| Dec 31, 2021 | 570.00 Mn |
| Sep 30, 2021 | 567.00 Mn |